Reported about 1 year ago
Preliminary results from Moderna's Phase-3 trial suggest a combined COVID-19-flu vaccine may boost immunity more effectively than separate shots, working well against various strains. Experts view combining flu and COVID-19 vaccines as a positive public health strategy that could increase vaccine uptake, especially in individuals hesitant about COVID-19 vaccines compared to flu shots. If approved, the combined vaccine could be available by the end of 2025. Additionally, the use of mRNA technology in vaccines, as pioneered by COVID-19 vaccines, opens up opportunities for broader applications beyond infectious diseases.
Source: YAHOO